Optieum Biotechnologies Inc.

Japan
Optieum Biotechnologies is a preclinical stage company dedicated to the discovery and development of next-generation CAR-T cell therapies for solid tumors, utilizing its proprietary Eumbody System to optimize CAR constructs.

Optieum Biotechnologies Inc. Offices

Hybrid Workspace

Employees engage in a combination of remote and on-site work.

Typical time on-site:
Japan